Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Chugai Pharmaceutical Co., Ltd.

Market Cap 12,379B 76.7B 67.02B 61.99B 57.86B 109B 7,248B 109B 737B 287B 3,563B 288B 282B P/E 2026 *
24.2x
P/E 2027 * 20.9x
Enterprise Value 11,457B 70.98B 62.02B 57.37B 53.55B 101B 6,708B 101B 682B 265B 3,298B 266B 261B EV / Sales 2026 *
8.26x
EV / Sales 2027 * 7.3x
Free-Float
38.12%
Yield 2026 *
1.82%
Yield 2027 * 2.08%
1 day-0.37%
1 week+0.97%
Current month-4.69%
1 month-4.01%
3 months-13.04%
6 months-9.28%
Current year-8.75%
1 week 7,386
Extreme 7386
7,719
1 month 7,270
Extreme 7270
8,215
Current year 7,270
Extreme 7270
10,700
1 year 5,942
Extreme 5942
10,700
3 years 3,767
Extreme 3767
10,700
5 years 3,191
Extreme 3191
10,700
10 years 1,003.33
Extreme 1003.3333
10,700
Manager TitleAgeSince
Chief Executive Officer 63 2020-12-31
Director of Finance/CFO - 2024-03-27
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 68 1993-02-28
Director/Board Member 81 2015-02-28
Director/Board Member 77 2017-02-28
Change 5-day change 1-year change 3-year change Capi.($)
-0.37%+0.97%+4.63%+74.77% 77.05B
+1.19%-1.63%+44.16%+142.74% 980B
+1.16%-1.83%+52.88%+39.68% 550B
+6.94%+4.52%+26.04%+68.56% 382B
-0.06%-3.09%+23.33%+16.78% 316B
+0.42%+0.68%+27.54%+14.57% 272B
+1.67%+0.05%+26.50%+33.56% 268B
+2.39%+5.02%-33.44%-44.76% 199B
+1.94%-1.62%+26.57%+50.15% 182B
+0.58%+0.31%+17.41%+59.62% 154B
Average +1.57%-2.29%+21.56%+45.57% 337.94B
Weighted average by Cap. +1.71%-3.39%+31.21%+65.48%

Financials

2026 *2027 *
Net sales 1,387B 8.59B 7.51B 6.95B 6.48B 12.17B 812B 12.26B 82.53B 32.11B 399B 32.26B 31.56B 1,535B 9.51B 8.31B 7.69B 7.17B 13.47B 899B 13.57B 91.35B 35.54B 442B 35.71B 34.93B
Net income 511B 3.16B 2.76B 2.56B 2.39B 4.48B 299B 4.51B 30.39B 11.82B 147B 11.88B 11.62B 593B 3.67B 3.21B 2.97B 2.77B 5.2B 347B 5.24B 35.3B 13.73B 171B 13.8B 13.5B
Net Debt -923B -5.72B -4.99B -4.62B -4.31B -8.09B -540B -8.15B -54.9B -21.36B -266B -21.46B -20.99B -1,166B -7.22B -6.31B -5.84B -5.45B -10.23B -682B -10.3B -69.37B -26.99B -336B -27.12B -26.53B
Logo Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The Company operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.
Employees
5,104
Date Price Change Volume
26-06-22 7,522.00 ¥ -0.37% 1,238,100
26-06-19 7,550.00 ¥ -0.21% 3,697,700
26-06-18 7,566.00 ¥ -1.10% 1,954,000
26-06-17 7,650.00 ¥ +1.69% 1,745,000
26-06-16 7,523.00 ¥ +1.28% 2,083,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
7,550.00JPY
Average target price
9,973.33JPY
Spread / Average Target
+32.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4519 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!